{"entity":{"id":"ex-vivo-cell-expansion","kind":"term","name":"Ex vivo cell expansion","aka":["cell culture expansion","fold expansion","cell enrichment versus expansion"],"tldr":"Cell expansion increases the number of a defined group of living cells outside the body. Selecting cells or activating them answers a different question.","summary":"Expansion compares absolute counts of a specified living population at stated points in a culture process. Enrichment or selection changes mixture composition, while activation changes cellular state. Measurements need a consistent cell definition, viability basis, sampling method and interval. Cell concentration can change with dilution or volume, and a higher fraction can result from losing other cells rather than producing more intended cells.","asOf":"2026-11-09","links":[{"label":"FDA: CAR T-cell development guidance, January 2024","url":"https://www.fda.gov/media/156896/download"},{"label":"Ghassemi et al., 2018: defined culture-duration comparisons and mouse experiments","url":"https://pubmed.ncbi.nlm.nih.gov/30030295/"},{"label":"Dupouy et al., 2022: factory expansion and adult CALM cellular kinetics","url":"https://pubmed.ncbi.nlm.nih.gov/36970059/"}],"tags":[],"related":["car-t-manufacturing-process","cell-therapy-cold-chain","cellular-kinetics-and-persistence","cell-manufacturing-outcomes"],"cancers":[],"sections":["cell-therapy"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["In a fictional mixture, 20 million intended cells and 80 million other cells become 20 million intended and five million other cells after enrichment. The intended fraction rises from 20/100 to 20/25 without increasing the intended-cell count. In a separate culture example, 20 million viable intended cells becoming 100 million is five-fold expansion. These are invented arithmetic examples, not process-performance targets.","Culture conditions, activation, gene transfer, duration, selection and preservation can change subsets, differentiation, viability and function. A greater count does not establish equal starting-cell quality, a favourable state or greater tumour killing. Activation markers and intended biological activity require suitable separate measurements.","Ghassemi's 2018 study compared shorter and longer preparation in human CAR T-cell experiments, a mouse acute-lymphoblastic-leukaemia model and manufacturing-feasibility work. The reported culture comparison does not prove that every shorter process improves human outcomes or specify one optimal duration for all products.","Dupouy's adult CALM analysis distinguishes factory fold expansion from later blood transgene and flow-cytometry kinetics. In-body detection depends on sampling, proliferation, distribution, loss and expression. A blood copy count is not an absolute whole-body count or a direct functional assay.","Expansion can be one input to a product-specific control strategy. It does not replace identity, purity, viability, potency, contamination testing, lot disposition or clinical readiness. Manufacturing yield, culture time, collection-to-infusion time and patient benefit remain separate outcomes."],"category":"Biology basics"},"route":"/terms/ex-vivo-cell-expansion/","neighbours":{"technology":[{"id":"car-t-manufacturing-process","kind":"technology","name":"Autologous CAR-T manufacturing, batch by batch","route":"/technologies/car-t-manufacturing-process/"},{"id":"cell-therapy-cold-chain","kind":"technology","name":"Cryopreservation and cell-therapy cold chain","route":"/technologies/cell-therapy-cold-chain/"},{"id":"in-vivo-car-t","kind":"technology","name":"In vivo CAR-T","route":"/technologies/in-vivo-car-t/"}],"term":[{"id":"apheresis","kind":"term","name":"Apheresis (leukapheresis)","route":"/terms/apheresis/"},{"id":"cell-manufacturing-outcomes","kind":"term","name":"Cell-manufacturing outcomes and nonconforming products","route":"/terms/cell-manufacturing-outcomes/"},{"id":"cellular-kinetics-and-persistence","kind":"term","name":"Cellular kinetics and persistence","route":"/terms/cellular-kinetics-and-persistence/"}],"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"}]}}